{"id":"etanerept","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Enbrel"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:45:54.733Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00110981","phase":"PHASE4","title":"Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis","status":"COMPLETED","sponsor":"Amgen","startDate":"2005-03","conditions":"Psoriasis","enrollment":86}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ARTHRITIS BACTERIAL"},{"count":1,"reaction":"CONSTIPATION"},{"count":1,"reaction":"DEEP VEIN THROMBOSIS"},{"count":1,"reaction":"DIVERTICULAR PERFORATION"},{"count":1,"reaction":"INTESTINAL PERFORATION"},{"count":1,"reaction":"MYOCARDIAL INFARCTION"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Etanerept","genericName":"Etanerept","companyName":"Amgen","companyId":"amgen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}